Review
Published on 03 Sep 2024
Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1451474
- 2,228 views
Type at least 3 characters
7,243 articles
Articles
Original Research
Published on 03 Sep 2024
Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1463574
- 1,687 views
Review
Published on 03 Sep 2024
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1460282
- 3,249 views
- 3 citations
Original Research
Published on 03 Sep 2024
Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1455019
- 2,175 views
Editorial
Published on 03 Sep 2024
Editorial: Multidimensionally decoding the impact of tumor heterogeneity on immunotherapy responsiveness in gastrointestinal tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1482206
- 853 views
- 1 citation
Review
Published on 03 Sep 2024
Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1438235
- 2,099 views
- 1 citation
Original Research
Published on 03 Sep 2024
Deciphering colorectal cancer radioresistance and immune microrenvironment: unraveling the role of EIF5A through single-cell RNA sequencing and machine learning
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1466226
- 2,762 views
- 1 citation
Review
Published on 03 Sep 2024
Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1457189
- 2,887 views
Case Report
Published on 03 Sep 2024
Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1441404
- 1,657 views
- 1 citation
Review
Published on 02 Sep 2024
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1429836
- 2,318 views
- 3 citations
Original Research
Published on 02 Sep 2024
Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1402951
- 2,688 views
- 2 citations
Original Research
Published on 02 Sep 2024
Exploiting branched-chain amino acid metabolism and NOTCH3 expression to predict and target colorectal cancer progression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1430352
- 1,407 views
Original Research
Published on 02 Sep 2024
Prognostic cellular senescence-related lncRNAs patterns to predict clinical outcome and immune response in colon cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450135
- 1,734 views
- 1 citation
Review
Published on 30 Aug 2024
Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1457629
- 4,126 views
- 2 citations
Review
Published on 30 Aug 2024
γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1438962
- 1,393 views
Review
Published on 30 Aug 2024
Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1444437
- 2,673 views
- 3 citations